CRESPONSE
LIVE

Serial Number

98560183

Owner

Curesponse Ltd.

Attorney

Evan Schechter

Filing Date

May 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CRESPONSE Trademark

Serial Number: 98560183

CRESPONSE is a trademark filed by Curesponse Ltd. on May 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Curesponse Ltd. (3 trademarks)

6 Weitzman Street
Tel Aviv 6423906 , IL

Entity Type: 99

Trademark Details

Filing Date

May 20, 2024

Registration Date

Not Registered

Published for Opposition

April 1, 2025

Goods & Services

Diagnostic testing materials, namely, specialized biological tissue culture for medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use, namely cancer research; biological tissue cultures for medical purposes

Laboratory testing of materials in the nature of analysis in the field of cancer testing and pathology; medical research laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation

Medical testing for diagnostic or treatment purposes; Providing medical testing services in the field of diagnosis and treatment of cancer diseases; medical testing services for diagnostic or treatment purposes in the field of optimization of pharmaceutical treatment for cancer patients; provision of medical information in the field of cancer screening, diagnosis and treatment; health care services for treating cancer; providing medical testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 26, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 26, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 26, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 27, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2024 NWOS
NEW APPLICATION ENTERED
May 21, 2024 NWAP